Nanomedicines-

Nanomedicine is a discipline of medicine that employs nanotechnology's knowledge and techniques to illness prevention and treatment. Nanomedicine is the use of tiny materials in living organisms, such as biocompatible nanoparticles and nanorobots, for diagnostics, delivery, sensing, and actuation.

Nanomedicine is the use of nanotechnology in medicine. Nanomedicine encompasses everything from medicinal nanomaterials and biological devices to nanoelectronic biosensors and potentially future molecular nanotechnology applications such as biological machines.

Nanomedicine offers unique advantages in the treatment of human cancers. Nanomedicine has opened up new therapeutic pathways for combating viral infections and improving treatment outcomes. Nucleic acid medicines are pharmaceuticals made from nucleic acids like DNA and RNA (which govern genetic information). Nucleic acid medicine is a next-generation drug development approach that works in a radically different way than traditional pharmaceuticals.

The development of innovative nanocarriers and drug delivery technologies is essential for nanomedicine to advance. However, there is still a lot to learn in the rapidly developing field of nanomedicine. In this paper, we look at how nanotechnology and nanomedicine can be used to cure cancer. The development of cancer nanomedicine has historically centred on enhancing the transport and potency of cytotoxic medicines into cancer cells.. It is also being considered the creation of immune-modulatory nanomedicine for cancer immunotherapy applications. Green nanomedicine refers to the impact of environmentally friendly and safe chemistry on the field of nanotechnology-driven medicinal delivery.

The use of multifunctional nanoparticles as a therapeutic module in nanomedicine-based targeted delivery systems promises a fantastic path for breast cancer treatment. Many nanoparticle-based formulations and technologies have already been deployed in the clinic, making nanomedicine a hot topic in preclinical research. Over the last two decades, researchers have made significant progress in developing several types of nanoparticles (NPs) for application in all aspects of breast cancer diagnosis and therapy. Nanomedicines have been developed for use as tumour imaging agents, drug delivery vehicles, and therapeutic components in tumour cell death employing hybrid nanostructures. This chapter discusses recent research on the use of nanomedicine in the diagnosis, treatment, and monitoring of breast cancer patients. The connection between nanomedicine and breast cancer therapies is established in this chapter. The present clinical environment is highlighted as well as a comprehensive assessment of nanomedicine technologies that are currently being examined in clinical trials.